Based on a previous study showing the effects of LCLT as a possible inhibitor of SARS-CoV-2 infection due to ACE-1 inhibition (12), we also sought here to evaluate the preventive effects of LCLT supplementations on COVID-19 negative volunteers which living on households with COVID-19-infected people (Cohort 1). The gene discussed is ACE; the disease is COVID-19.